Tuttle Capital Management LLC Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Tuttle Capital Management LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 68.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,060 shares of the healthcare conglomerate’s stock after purchasing an additional 431 shares during the quarter. UnitedHealth Group accounts for 2.6% of Tuttle Capital Management LLC’s investment portfolio, making the stock its 11th biggest position. Tuttle Capital Management LLC’s holdings in UnitedHealth Group were worth $555,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. NewSquare Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the 4th quarter valued at $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $30,000. Finally, Promus Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $32,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have recently issued reports on UNH shares. Baird R W cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday. TD Securities reaffirmed a “hold” rating and issued a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Mizuho decreased their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. Wells Fargo & Company reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Friday, June 6th. Finally, Oppenheimer lowered their target price on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research note on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $426.52.

Insider Buying and Selling at UnitedHealth Group

In related news, Director John H. Noseworthy acquired 300 shares of the business’s stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the purchase, the director now owns 6,063 shares in the company, valued at $1,892,626.08. The trade was a 5.21% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Timothy Patrick Flynn bought 1,533 shares of the firm’s stock in a transaction on Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $313.39 on Friday. The business has a 50-day simple moving average of $386.66 and a two-hundred day simple moving average of $473.26. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market cap of $284.28 billion, a price-to-earnings ratio of 20.22, a price-to-earnings-growth ratio of 1.37 and a beta of 0.45. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the prior year, the business posted $6.91 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be issued a $2.21 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.82%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.